British Drugs Policy: Forty Years of the Same Policy Producing the Same Outcomes

British Drugs Policy: Forty Years of the Same Policy Producing the Same Outcomes

The Misuse of Drugs Act, Decriminalisation, Scotland Drug Deaths, Cannabis Policy, and the Evidence Accumulating Faster Than Policy Is Changing

British Drugs Policy: The Field Where Evidence Goes to Be Acknowledged and Then Set Aside

The United Kingdom’s drug policy is governed principally by the Misuse of Drugs Act 1971, which classified controlled substances into three categories and established criminal penalties for possession and supply. In the fifty years since, the evidence base has grown substantially: longitudinal studies of drug harm, comparative analysis of different national approaches, and specific public health data from Scotland, which has the highest drug death rate in Europe, have consistently pointed in directions the Act’s framework makes difficult to follow. The evidence shows that criminal penalties for personal possession do not significantly deter use; treatment and harm reduction are more cost-effective than enforcement; and the drug death rate is substantially higher in countries without drug consumption rooms and expanded naloxone availability. The policy conclusions are available, tested in comparable democracies, and politically difficult to implement because tough on drugs remains more comfortable than evidence-based on drugs.

Scotland’s Drug Deaths

Scotland recorded approximately 1,172 drug deaths in 2022 — the highest per capita rate in Europe, more than three times England and Wales. Deaths are concentrated in deprived communities among people using heroin and other opioids with histories of homelessness and contact with the criminal justice system. The Scottish Government has advocated for safe consumption rooms, which would allow people to use drugs under clinical supervision and receive overdose reversal if needed. But the Misuse of Drugs Act, reserved to Westminster, does not permit safe consumption rooms without legislative change. Westminster has declined to provide that change. Scotland is constitutionally unable to implement the intervention most likely to reduce deaths because the constitutional settlement allocates drug law to Westminster and Westminster’s political appetite for reform has been inadequate to the mortality data Scotland is generating.

Cannabis and the Advisory Council

Cannabis is classified as Class B — reduced to Class C in 2004, reversed to Class B in 2008 against Advisory Council on the Misuse of Drugs advice. Professor David Nutt was subsequently dismissed for publishing a paper finding alcohol more harmful than cannabis, and proceeded to publish similar findings in peer-reviewed journals. Cannabis legalisation has been implemented in Canada (2018), most US states, and Germany (2024), with outcomes showing modest increases in adult use, reduced criminal justice costs, tax revenues, and no catastrophic social consequences. The ACMD is a statutory body whose advice the Home Secretary must consider but is not required to follow. The gap between consider and follow has been productively exploited. The arrangement represents British institutional governance at its most managed: create a statutory advisory body, provide statutory authority for ignoring its advice, and maintain the appearance of evidence-based policy while practising something rather different.

Auf Wiedersehen, amigo!

The Misuse of Drugs Act 1971 classifies substances into Classes A, B, and C. Scotland recorded approximately 1,172 drug deaths in 2022, the highest per capita rate in Europe. Safe consumption rooms require Westminster legislation that has not been provided; drug law is reserved. Cannabis was downgraded to Class C in 2004 and upgraded back to Class B in 2008 against ACMD advice. Professor David Nutt was dismissed from the ACMD in 2009 for publishing evidence that alcohol was more harmful than cannabis. Canada legalised cannabis in 2018; Germany legalised personal possession in 2024.

Leave a Reply

Your email address will not be published. Required fields are marked *